Cargando…

SUMO fusion technology for difficult-to-express proteins

The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents man...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Tauseef R., Edavettal, Suzanne C., Hall, John P., Mattern, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129290/
https://www.ncbi.nlm.nih.gov/pubmed/16084395
http://dx.doi.org/10.1016/j.pep.2005.03.016
_version_ 1783516752462741504
author Butt, Tauseef R.
Edavettal, Suzanne C.
Hall, John P.
Mattern, Michael R.
author_facet Butt, Tauseef R.
Edavettal, Suzanne C.
Hall, John P.
Mattern, Michael R.
author_sort Butt, Tauseef R.
collection PubMed
description The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents many challenges which must be surmounted in order to over-express heterologous proteins. These challenges include the proteolytic degradation of target proteins, protein misfolding, poor solubility, and the necessity for good purification methodologies. Gene fusion technologies have been able to improve heterologous expression by overcoming many of these challenges. The ability of gene fusions to improve expression, solubility, purification, and decrease proteolytic degradation will be discussed in this review. The main disadvantage, cleaving the protein fusion, will also be addressed. Focus will be given to the newly described SUMO fusion system and the improvements that this technology has advanced over traditional gene fusion systems.
format Online
Article
Text
id pubmed-7129290
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71292902020-04-08 SUMO fusion technology for difficult-to-express proteins Butt, Tauseef R. Edavettal, Suzanne C. Hall, John P. Mattern, Michael R. Protein Expr Purif Article The demands of structural and functional genomics for large quantities of soluble, properly folded proteins in heterologous hosts have been aided by advancements in the field of protein production and purification. Escherichia coli, the preferred host for recombinant protein expression, presents many challenges which must be surmounted in order to over-express heterologous proteins. These challenges include the proteolytic degradation of target proteins, protein misfolding, poor solubility, and the necessity for good purification methodologies. Gene fusion technologies have been able to improve heterologous expression by overcoming many of these challenges. The ability of gene fusions to improve expression, solubility, purification, and decrease proteolytic degradation will be discussed in this review. The main disadvantage, cleaving the protein fusion, will also be addressed. Focus will be given to the newly described SUMO fusion system and the improvements that this technology has advanced over traditional gene fusion systems. Elsevier Inc. 2005-09 2005-04-09 /pmc/articles/PMC7129290/ /pubmed/16084395 http://dx.doi.org/10.1016/j.pep.2005.03.016 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Butt, Tauseef R.
Edavettal, Suzanne C.
Hall, John P.
Mattern, Michael R.
SUMO fusion technology for difficult-to-express proteins
title SUMO fusion technology for difficult-to-express proteins
title_full SUMO fusion technology for difficult-to-express proteins
title_fullStr SUMO fusion technology for difficult-to-express proteins
title_full_unstemmed SUMO fusion technology for difficult-to-express proteins
title_short SUMO fusion technology for difficult-to-express proteins
title_sort sumo fusion technology for difficult-to-express proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129290/
https://www.ncbi.nlm.nih.gov/pubmed/16084395
http://dx.doi.org/10.1016/j.pep.2005.03.016
work_keys_str_mv AT butttauseefr sumofusiontechnologyfordifficulttoexpressproteins
AT edavettalsuzannec sumofusiontechnologyfordifficulttoexpressproteins
AT halljohnp sumofusiontechnologyfordifficulttoexpressproteins
AT matternmichaelr sumofusiontechnologyfordifficulttoexpressproteins